ZERIT - 53808-0657-1 - (stavudine)

Alphabetical Index


Drug Information of ZERIT

Product NDC: 53808-0657
Proprietary Name: ZERIT
Non Proprietary Name: stavudine
Active Ingredient(s): 30    mg/1 & nbsp;   stavudine
Administration Route(s): ORAL
Dosage Form(s): CAPSULE, GELATIN COATED
Coding System: National Drug Codes(NDC)

Labeler Information of ZERIT

Product NDC: 53808-0657
Labeler Name: State of Florida DOH Central Pharmacy
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020412
Marketing Category: NDA
Start Marketing Date: 20090701

Package Information of ZERIT

Package NDC: 53808-0657-1
Package Description: 30 CAPSULE, GELATIN COATED in 1 BLISTER PACK (53808-0657-1)

NDC Information of ZERIT

NDC Code 53808-0657-1
Proprietary Name ZERIT
Package Description 30 CAPSULE, GELATIN COATED in 1 BLISTER PACK (53808-0657-1)
Product NDC 53808-0657
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name stavudine
Dosage Form Name CAPSULE, GELATIN COATED
Route Name ORAL
Start Marketing Date 20090701
Marketing Category Name NDA
Labeler Name State of Florida DOH Central Pharmacy
Substance Name STAVUDINE
Strength Number 30
Strength Unit mg/1
Pharmaceutical Classes Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA]

Complete Information of ZERIT


General Information